Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
Total Valuation
Inspire Medical Systems has a market cap or net worth of $1.77B. The enterprise value is $1.73B.
Market Cap$1.77B
Enterprise Value$1.73B
Share Statistics
Inspire Medical Systems has 28,589,290 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,589,290
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Inspire Medical Systems’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 6.25%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)6.25%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee731.93K
Profits Per Employee116.71K
Employee Count1,246
Asset Turnover1.01
Inventory Turnover0.92
Valuation Ratios
The current PE Ratio of Inspire Medical Systems is 12.0. Inspire Medical Systems’s PEG ratio is 0.11.
PE Ratio12.0
PS Ratio2.97
PB Ratio3.47
Price to Fair Value3.47
Price to FCF34.52
Price to Operating Cash Flow14.79
PEG Ratio0.11
Income Statement
In the last 12 months, Inspire Medical Systems had revenue of 911.98M and earned 145.42M in profits. Earnings per share was 4.95.
Revenue911.98M
Gross Profit778.76M
Operating Income50.95M
Pretax Income65.70M
Net Income145.42M
EBITDA64.91M
Earnings Per Share (EPS)4.95
Cash Flow
In the last 12 months, operating cash flow was 116.98M and capital expenditures -38.50M, giving a free cash flow of 78.48M billion.
Operating Cash Flow116.98M
Free Cash Flow78.48M
Free Cash Flow per Share2.74
Dividends & Yields
Inspire Medical Systems pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.44
52-Week Price Change-66.29%
50-Day Moving Average90.95
200-Day Moving Average103.74
Relative Strength Index (RSI)26.27
Average Volume (3m)1.33M
Important Dates
Inspire Medical Systems upcoming earnings date is May 5, 2026, After Close (Confirmed).
Last Earnings DateFeb 11, 2026
Next Earnings DateMay 5, 2026
Ex-Dividend Date―
Financial Position
Inspire Medical Systems as a current ratio of 6.08, with Debt / Equity ratio of 4.12%
Current Ratio6.08
Quick Ratio4.56
Debt to Market Cap0.01
Net Debt to EBITDA-0.66
Interest Coverage Ratio371.93
Taxes
In the past 12 months, Inspire Medical Systems has paid -79.72M in taxes.
Income Tax-79.72M
Effective Tax Rate-1.21
Enterprise Valuation
Inspire Medical Systems EV to EBITDA ratio is 41.07, with an EV/FCF ratio of 33.97.
EV to Sales2.92
EV to EBITDA41.07
EV to Free Cash Flow33.97
EV to Operating Cash Flow22.79
Balance Sheet
Inspire Medical Systems has $308.27M in cash and marketable securities with $32.16M in debt, giving a net cash position of $276.11M billion.
Cash & Marketable Securities$308.27M
Total Debt$32.16M
Net Cash$276.11M
Net Cash Per Share$9.66
Tangible Book Value Per Share$26.60
Margins
Gross margin is 85.39%, with operating margin of 5.59%, and net profit margin of 15.95%.
Gross Margin85.39%
Operating Margin5.59%
Pretax Margin7.20%
Net Profit Margin15.95%
EBITDA Margin7.12%
EBIT Margin5.59%
Analyst Forecast
The average price target for Inspire Medical Systems is $91.62, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$91.62
Price Target Upside53.26% Upside
Analyst ConsensusModerate Buy
Analyst Count18
Revenue Growth Forecast16.81%
EPS Growth Forecast34.90%